X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (188) 188
Patent (35) 35
Publication (22) 22
Book Chapter (2) 2
Conference Proceeding (2) 2
Book / eBook (1) 1
Dissertation (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (88) 88
oncology (73) 73
index medicus (64) 64
female (52) 52
animals (40) 40
cancer (39) 39
mice (38) 38
human necessities (33) 33
hygiene (33) 33
medical or veterinary science (33) 33
preparations for medical, dental, or toilet purposes (33) 33
t cells (32) 32
bone-marrow (30) 30
immunology (29) 29
immunotherapy (29) 29
expression (28) 28
middle aged (28) 28
aged (26) 26
cancer research (26) 26
investigating or analysing materials by determining theirchemical or physical properties (26) 26
measuring (26) 26
physics (26) 26
research (26) 26
t-lymphocytes - immunology (26) 26
testing (26) 26
chemistry (25) 25
metallurgy (25) 25
lymphocytes (24) 24
male (23) 23
tumors (22) 22
adult (20) 20
antigens, neoplasm - immunology (20) 20
peptides (20) 20
care and treatment (19) 19
breast neoplasms - immunology (18) 18
specific therapeutic activity of chemical compounds ormedicinal preparations (18) 18
beer (17) 17
biochemistry (17) 17
breast cancer (17) 17
compositions thereof (17) 17
culture media (17) 17
enzymology (17) 17
microbiology (17) 17
microorganisms or enzymes (17) 17
mutation or genetic engineering (17) 17
propagating, preserving or maintaining microorganisms (17) 17
spirits (17) 17
t-lymphocytes, regulatory - immunology (17) 17
vinegar (17) 17
wine (17) 17
breast neoplasms - pathology (16) 16
cd8-positive t-lymphocytes - immunology (16) 16
dendritic cells (16) 16
oncology, experimental (15) 15
analysis (14) 14
antigen (14) 14
bone marrow cells - immunology (14) 14
immunologic memory (14) 14
medicine & public health (14) 14
prognosis (14) 14
flow cytometry (13) 13
mice, inbred nod (13) 13
organic chemistry (13) 13
therapy (13) 13
cd4-positive t-lymphocytes - immunology (12) 12
health aspects (12) 12
in-vivo (12) 12
mice, scid (12) 12
survival (12) 12
abridged index medicus (11) 11
cell biology (11) 11
cell line, tumor (11) 11
identification (11) 11
immunotherapy - methods (11) 11
medicine, research & experimental (11) 11
neoplasm metastasis (11) 11
neoplasms - immunology (11) 11
regulatory t cells (11) 11
breast-cancer (10) 10
colorectal cancer (10) 10
melanoma (10) 10
phenotype (10) 10
universities and colleges (10) 10
antigens (9) 9
bone marrow (9) 9
carcinoma (9) 9
chemical and pharmacologic phenomena (9) 9
colorectal neoplasms - immunology (9) 9
colorectal-cancer (9) 9
enzyme-linked immunosorbent assay (9) 9
lymphocyte activation (9) 9
metastasis (9) 9
pancreatic cancer (9) 9
regulatory t-cells (9) 9
cancer patients (8) 8
cells, cultured (8) 8
dendritic cells - immunology (8) 8
development and progression (8) 8
genetics (8) 8
hemic and immune systems (8) 8
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


BMC Cancer, ISSN 1471-2407, 08/2012, Volume 12, Issue 1, pp. 361 - 361
Background: The investigational oral DNA vaccine VXM01 targets the vascular endothelial growth factor receptor 2 (VEGFR-2) and uses Salmonella typhi Ty21a as a... 
DNA vaccine | Cancer vaccine | Oral vaccine | Anti-angiogenesis | Pancreatic cancer | VEGFR-2 | DENDRITIC CELLS | BEVACIZUMAB | SALMONELLA-TYPHI | TUMOR ANGIOGENESIS | OVARIAN-CANCER | RENAL-CELL CARCINOMA | ONCOLOGY | GROWTH | PHASE-3 TRIAL | Randomized Controlled Trials as Topic - methods | Humans | Pancreatic Neoplasms - blood supply | Vaccines, DNA - immunology | Deoxycytidine - pharmacology | Vascular Endothelial Growth Factor Receptor-2 - immunology | Vaccines, DNA - administration & dosage | Vascular Endothelial Growth Factor Receptor-2 - genetics | Pancreatic Neoplasms - drug therapy | Deoxycytidine - therapeutic use | Clinical Trials, Phase I as Topic - methods | Placebos | Adult | Antimetabolites, Antineoplastic - pharmacology | Neovascularization, Pathologic - prevention & control | Neovascularization, Pathologic - immunology | Pancreatic Neoplasms - prevention & control | Salmonella typhi - genetics | Double-Blind Method | Administration, Oral | Cancer Vaccines - administration & dosage | Cancer Vaccines - adverse effects | Cancer Vaccines - immunology | Antimetabolites, Antineoplastic - therapeutic use | Neovascularization, Pathologic - drug therapy | Pancreatic Neoplasms - immunology | Vaccines, DNA - adverse effects | Deoxycytidine - analogs & derivatives | Care and treatment | Immunotherapy | Physiological aspects | DNA vaccines | Research | Vascular endothelial growth factor | Medical research | Cancer patients | Immune response | Medicine, Experimental | Vaccines | Contamination | Cancer | Endothelium | Cancer vaccines | Immunogenicity | Clinical trials | Data processing | gemcitabine | Colony-forming cells | Vascular endothelial growth factor receptor 2 | Tumors | Vascular endothelial growth factor receptors
Journal Article
Nature, ISSN 0028-0836, 08/2014, Volume 512, Issue 7514, pp. 324 - 327
Journal Article
Cancer Immunology, Immunotherapy, ISSN 0340-7004, 3/2012, Volume 61, Issue 3, pp. 353 - 362
Severe immune suppression is frequent in late-stage tumor patients and promotes tumor immune evasion and subsequent tumor progression. Regulatory T cells... 
Tumor-specific T cells | Immunology | Low-dose cyclophosphamide | Medicine & Public Health | Immunomodulation | Oncology | Cancer Research | Breast cancer | Regulatory T cells | BONE-MARROW | OVARIAN-CANCER | IMMUNOLOGY | ANTITUMOR-ACTIVITY | TUMOR-IMMUNITY | METASTATIC MELANOMA | IN-VITRO | ONCOLOGY | AUTOIMMUNITY | REGULATORY T-CELLS | CARCINOMA | T-Lymphocytes, Regulatory - metabolism | Cyclophosphamide - administration & dosage | Breast Neoplasms - immunology | Humans | Middle Aged | Antineoplastic Agents, Alkylating - administration & dosage | Interferon-gamma - metabolism | Cyclophosphamide - therapeutic use | T-Lymphocytes, Regulatory - immunology | CD4-Positive T-Lymphocytes - immunology | Dose-Response Relationship, Drug | T-Lymphocytes, Cytotoxic - drug effects | Neoplasm Metastasis | Time Factors | U937 Cells | CD8-Positive T-Lymphocytes - metabolism | Adult | Female | T-Lymphocytes, Cytotoxic - immunology | CD4-Positive T-Lymphocytes - metabolism | Treatment Outcome | Breast Neoplasms - drug therapy | Antineoplastic Agents, Alkylating - therapeutic use | T-Lymphocytes, Regulatory - drug effects | T-Lymphocytes, Cytotoxic - metabolism | Breast Neoplasms - pathology | CD8-Positive T-Lymphocytes - drug effects | Interferon-gamma - immunology | Survival Analysis | Cell Line, Tumor | Lymphocyte Count | Aged | CD8-Positive T-Lymphocytes - immunology | CD4-Positive T-Lymphocytes - drug effects | Care and treatment | Patient outcomes | Oncology, Experimental | Development and progression | Research | Antineoplastic agents | T cells | Cells | Antimitotic agents | Cancer patients | Cyclophosphamide | Universities and colleges | Drug therapy | Cancer | Tumors | Cell survival | Immunoregulation | Immunotherapy | Lymphocytes T
Journal Article
Journal of Clinical Investigation, ISSN 0021-9738, 02/2015, Volume 125, Issue 2, pp. 739 - 751
The composition of tumor-targeted T cell infiltrates is a major prognostic factor in colorectal cancer (CRC) outcome; however, the functional role of these... 
MEDICINE, RESEARCH & EXPERIMENTAL | IMMUNE CELLS | METASTASIS | CELL RESPONSES | MEMORY | IMMUNOTHERAPY | CHEMOKINES | BONE-MARROW | TNF-ALPHA | BREAST | INFILTRATION | Physiological aspects | Prognosis | T cells | Properties | Analysis | Colorectal cancer | Studies | Antigens | Survival analysis | Cloning | Medical prognosis | Biomarkers | Cytotoxicity | Software | Patients | Tumors
Journal Article
Journal Article
Journal Article
Journal Article